nafamostat has been researched along with Arrhythmias, Cardiac in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uchino, S | 1 |
| Bellomo, R | 1 |
| Morimatsu, H | 1 |
| Morgera, S | 1 |
| Schetz, M | 1 |
| Tan, I | 1 |
| Bouman, C | 1 |
| Macedo, E | 1 |
| Gibney, N | 1 |
| Tolwani, A | 1 |
| Oudemans-van Straaten, H | 1 |
| Ronco, C | 1 |
| Kellum, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PrEvalence of Acute and Chronic Kidney Disease Treated by Renal Replacement Therapy in the ICU Environment[NCT02341885] | 2,000 participants (Actual) | Observational | 2015-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for nafamostat and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators.
Topics: Acute Kidney Injury; Aged; Anticoagulants; Arrhythmias, Cardiac; Benzamidines; Citrates; Drug Utiliz | 2007 |